Programmed death ligand 1 (PD-L1), a transmembrane protein highly expressed on the surface of tumor cells, inhibits T-cell function by binding to programmed death receptor 1 (PD-1), leading to tumor immune escape (56, 57). This evidence concerns the gene CD274 and neoplasm.